ACE and obesity due to melanocortin 4 receptor deficiency: Concerning comorbidities, 16.9% had obesity, 15.8% were smoker or ex-smokers, 49.2% had hypertension, 32.1% of them were treated with ACEIs (angiotensin converting enzyme inhibitors) and 33% with ARBs (angiotensin receptor blockers).